MoonLake Immunotherapeutics (MLTX) Net Equity Issued and Repurchased (2023 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Net Equity Issued and Repurchased of $6.0 million for Q1 2026, down 88.57% quarter-over-quarter from $52.5 million in Q1 2024.
MoonLake Immunotherapeutics (MLTX) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $6.0 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | 44.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 44.31 Mn |
| Jun 30, 2026 | 44.31 Mn |
| Mar 31, 2026 | 6.01 Mn |
| Mar 31, 2026 | 6.01 Mn |
| Mar 31, 2024 | 52.54 Mn |
| Mar 31, 2024 | 52.54 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Jun 30, 2023 | 14.60 Mn |